US Patent 11890325 Therapeutic uses of dulaglutide
Patent 11890325 was granted and assigned to Eli Lilly and Company on February, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11890325 Therapeutic uses of dulaglutide
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.